Haba Laboratories

Haba Laboratories Forward P/E

The Forward P/E Ratio of Haba Laboratories (4925.T) as of Oct 17, 2026 is 8.65. In the previous year, Forward P/E Ratio was 11.41 — a change of -24.17% (lower).

Forward P/E

8.65

YoY

-24.17%

Last updated:

Forward P/E Ratio of Haba Laboratories is 2026 8.65 . Forward P/E Ratio of Haba Laboratories was 2025 11.41 . It decreases by -24.17% lower compared to the previous year.

The Haba Laboratories Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2019
3.15 JPY
Jan 1, 2020
5.01 JPY
Jan 1, 2021
30.39 JPY
Jan 1, 2022
-24.44 JPY
Jan 1, 2023
-9.29 JPY
Jan 1, 2024
-3.10 JPY
Jan 1, 2025
11.41 JPY
Jan 1, 2026
8.65 JPY
The Haba Laboratories Forward P/E history
YEARForward P/EYoY
8.65-24.17%
11.41-467.46%
-3.10-66.59%
-9.29-61.99%
-24.44-180.44%
30.39+506.91%
5.01+59.00%
3.15-23.49%
4.12-24.05%
5.42-19.05%
6.69-95.44%
146.68+1,943.88%
7.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Haba Laboratories Stock analysis

What does Haba Laboratories do? Haba Laboratories Inc, listed on the Tokyo Stock Exchange with ticker 4925.T and ISIN JP3765130004, is a Japanese company operating in the Consumer Staples sector under the Consumer products industry. Headquartered in Chiyoda-ku, Tokyo, the company employs 654 people. It went public on June 11, 2003. Haba Laboratories focuses on the development, manufacture, and sale of natural cosmetics, quasi-drugs, and nutritional supplements. The company distributes its products through wholesale channels to department stores, retailers, and wholesalers, as well as via mail order services to individual customers. It also operates its own retail stores for direct sales. The firm's product range includes cosmetics for both women and men, with an emphasis on natural formulations. Haba Laboratories maintains a website at http://www.haba.com/ for customer and investor information. The company's operations are based in Japan, reflecting its domestic market focus within the consumer goods sector. Its business model combines B2B wholesale distribution with direct-to-consumer sales channels, supporting a diversified revenue stream across multiple retail touchpoints. Haba Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Haba Laboratories stock

Forward P/E Ratio of Haba Laboratories is 8.65 in 2026.

Forward P/E Ratio of Haba Laboratories changed from 11.41 to 8.65, representing a -24.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Haba Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Haba Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Haba Laboratories

All Key Metrics — Haba Laboratories